Verastem, Inc. (VSTM)
NASDAQ: VSTM · Real-Time Price · USD
7.49
-0.01 (-0.13%)
At close: Apr 25, 2025, 4:00 PM
7.46
-0.03 (-0.40%)
After-hours: Apr 25, 2025, 5:52 PM EDT
Verastem Market Cap
Verastem has a market cap or net worth of $386.17 million as of April 25, 2025. Its market cap has increased by 35.12% in one year.
Market Cap
386.17M
Enterprise Value
339.61M
1-Year Change
35.12%
Ranking
Category
Stock Price
$7.49
Market Cap Chart
Since January 27, 2012, Verastem's market cap has increased from $213.30M to $386.17M, an increase of 81.05%. That is a compound annual growth rate of 4.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 386.20M | 67.84% |
| Dec 31, 2024 | 230.10M | 11.86% |
| Dec 29, 2023 | 205.70M | 143.14% |
| Dec 30, 2022 | 84.60M | -77.35% |
| Dec 31, 2021 | 373.50M | 3.29% |
| Dec 31, 2020 | 361.60M | 263.05% |
| Dec 31, 2019 | 99.60M | -59.81% |
| Dec 31, 2018 | 247.80M | 99.36% |
| Dec 29, 2017 | 124.30M | 200.24% |
| Dec 30, 2016 | 41.40M | -39.74% |
| Dec 31, 2015 | 68.70M | -70.98% |
| Dec 31, 2014 | 236.70M | -19.05% |
| Dec 31, 2013 | 292.40M | 56.53% |
| Dec 31, 2012 | 186.80M | -12.42% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 781.27B |
| UnitedHealth Group | 380.03B |
| Johnson & Johnson | 369.74B |
| AbbVie | 328.39B |
| Novo Nordisk | 276.96B |
| Abbott Laboratories | 222.31B |
| AstraZeneca | 215.41B |
| Novartis AG | 211.71B |